These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 18663625
1. Matrix metalloproteinase-2 and -9 levels in obese patients. Derosa G, Ferrari I, D'Angelo A, Tinelli C, Salvadeo SA, Ciccarelli L, Piccinni MN, Gravina A, Ramondetti F, Maffioli P, Cicero AF. Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625 [Abstract] [Full Text] [Related]
2. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Głowińska-Olszewska B, Urban M. Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313 [Abstract] [Full Text] [Related]
3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H. Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [Abstract] [Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W. Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181 [Abstract] [Full Text] [Related]
5. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM. Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250 [Abstract] [Full Text] [Related]
12. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Quijada Z, Paoli M, Zerpa Y, Camacho N, Cichetti R, Villarroel V, Arata-Bellabarba G, Lanes R. Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788 [Abstract] [Full Text] [Related]
13. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome. Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G. Angiology; 2007 Oct; 58(1):26-33. PubMed ID: 17351155 [Abstract] [Full Text] [Related]
18. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Belo VA, Souza-Costa DC, Lana CM, Caputo FL, Marcaccini AM, Gerlach RF, Bastos MG, Tanus-Santos JE. Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835 [Abstract] [Full Text] [Related]